
NGNE
Neurogene Inc.
$16.91
-$0.07(-0.41%)
63
Overall
--
Value
63
Tech
--
Quality
Market Cap
$248.90M
Volume
98.28K
52W Range
$6.88 - $74.49
Target Price
$47.40
Order:
Income Statement
Metric | Trend | Chart | 2014 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | -- | -- | -- | $25.0M | -- | -- | -- | -- | -- | $925.0K | ||
Total Revenue | -- | -- | -- | $25.0M | -- | -- | -- | -- | -- | $925.0K | ||
GROSS PROFIT | ||||||||||||
Gross Profit | -- | -- | -- | $25.0M | -- | -- | -- | -- | -- | $925.0K | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $-22.4M | $-37.6M | $-51.1M | $-57.6M | $71.0M | $41.6M | $60.7M | $56.5M | $55.6M | $83.5M | ||
Research & Development | $18.1M | $28.4M | $36.3M | $41.8M | $52.1M | $24.3M | $39.2M | $47.5M | $44.4M | $60.9M | ||
Research Expense | $18.1M | $28.4M | $36.3M | $41.8M | $4.4M | $24.3M | $39.2M | $47.5M | $44.4M | $60.9M | ||
Selling, General & Administrative | $4.3M | $9.3M | $14.9M | $15.8M | $18.8M | $17.2M | $21.5M | $9.0M | $11.2M | $22.6M | ||
General & Administrative Expenses | $4.3M | $9.3M | $14.9M | $15.8M | $18.8M | $17.2M | $21.5M | $9.0M | $11.2M | $22.6M | ||
Salaries & Wages | $-854.0K | $-2.0M | $-3.8M | $-4.7M | $-7.7M | -- | -- | -- | $1.4M | $8.3M | ||
Depreciation & Amortization | -- | -- | -- | $-300.0K | $-200.0K | $600.0K | $1.1M | $3.2M | $3.3M | $3.2M | ||
Depreciation & Amortization | -- | -- | -- | $-300.0K | $-200.0K | $600.0K | $1.1M | $3.2M | $3.3M | $3.2M | ||
Amortization | -- | -- | -- | -- | $-19.0K | $246.0K | $249.0K | $204.0K | $235.0K | $452.0K | ||
Other Operating Expenses | -- | -- | -- | $41.8M | $-197.0K | $3.1M | $4.8M | $-476.0K | $-574.0K | $-654.0K | ||
OPERATING INCOME | ||||||||||||
Operating income | $-22.4M | $-37.6M | $-51.1M | $-32.6M | $-71.0M | $-33.7M | $-60.7M | $-56.5M | $-55.6M | $-82.6M | ||
EBITDA | $-21.8M | $-37.0M | $-50.2M | $-31.3M | $-68.9M | $-31.4M | $-49.6M | $-52.0M | $-33.0M | $-71.9M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $461.6K | $1.0K | $4.0K | $4.0K | $1.0K | $14.0K | $-19.0K | $2.0K | $12.0K | $12.0K | ||
Intinc | $-2.3M | -- | -- | -- | $1.5M | -- | -- | $1.3M | $3.0M | $8.5M | ||
Net Non-Operating Interest Income/Expense | $-2.3M | $-1.0K | $-4.0K | $-4.0K | $1.5M | $-14.0K | $19.0K | $-1.3M | $3.0M | $8.5M | ||
Gain on Sale of Securities | $949.0K | $81.0K | -- | -- | -- | $490.0K | $19.0K | -- | -- | -- | ||
Other Income/Expense | $-694.0K | $-644.0K | $-940.0K | $-1.0M | $14.0K | $-8.3M | $13.0K | $-7.0K | $-16.3M | $994.0K | ||
Other Special Charges | $-255.0K | $644.0K | $940.0K | $1.0M | $-9.0K | $451.0K | $-13.0K | $-7.0K | $16.3M | $-994.0K | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | $1.4M | -- | -- | ||
Special Income Charges | -- | -- | -- | -- | -- | -- | -- | $-1.4M | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-24.0M | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-50.5M | $-55.2M | $-36.3M | $-75.1M | ||
Pre-Tax Income | $-24.0M | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-60.7M | $-55.2M | $-36.3M | $-75.1M | ||
INCOME TAX | ||||||||||||
Tax Provision | $-222 | $-231.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
NET INCOME | ||||||||||||
Net Income | $-24.0M | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-50.5M | $-55.2M | $-36.3M | $-75.1M | ||
Net Income (Continuing Operations) | $-24.0M | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-60.7M | $-55.2M | $-36.3M | $-75.1M | ||
Net Income (Discontinued Operations) | $-24.0M | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-50.5M | $-55.2M | $-36.3M | $-75.1M | ||
Net Income (Common Stockholders) | $-24.0M | $-37.0M | $-50.2M | $-31.6M | $-69.4M | $-33.3M | $-50.5M | $-55.2M | $-36.3M | $-75.1M | ||
Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-74.4M | ||
TOTALS | ||||||||||||
Total Expenses | $-22.4M | $-37.6M | $-51.1M | $-57.6M | $71.0M | $41.6M | $60.7M | $56.5M | $55.6M | $83.5M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $8.7M | $18.9M | $23.5M | $23.5M | $27.0M | $13.0M | $13.8M | $13.8M | $492.0K | $17.6M | ||
Average Shares Outstanding (Diluted) | $8.7M | $18.9M | $23.4M | $23.6M | $27.0M | $13.0M | $13.8M | $13.8M | $4.7M | $17.6M | ||
Shares Outstanding | $10.7M | $23.4M | $23.5M | $23.5M | $38.4M | $10.6M | $10.6M | $10.7M | $12.9M | $14.9M | ||
Basic EPS | -- | -- | -- | -- | -- | $-2.56 | $-4.4 | $-4.16 | $-73.82 | $-4.28 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-2.56 | $-4.4 | $-4.16 | -- | $-4.28 | ||
Diluted EPS | $-2.75 | $-1.96 | $-2.14 | $-1.34 | $-2.57 | $-2.56 | $-4.4 | $-4.16 | $-7.8 | $-4.28 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-2.57 | -- | $-4.4 | $-4.16 | -- | $-4.28 | ||
OTHER METRICS | ||||||||||||
Accretion On Preferred Stock | $-20.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Development Expense | -- | -- | -- | -- | $47.7M | -- | -- | -- | -- | -- | ||
Earnings from equity interest | -- | -- | -- | -- | -- | $7.8M | -- | -- | -- | -- | ||
Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | $7.8M | -- | -- | -- | -- | ||
Gain On Sale Of P P E | -- | -- | -- | -- | $-5.0K | $-180.0K | -- | $-118.0K | -- | -- | ||
Other Gand A | $4.3M | $9.3M | $14.9M | $15.8M | $18.8M | $17.2M | $21.5M | $9.0M | $11.2M | $22.6M | ||
Otherunder Preferred Stock Dividend | $-20.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Preferred Stock Dividends | $-20.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Rent And Landing Fees | $4.3M | $9.3M | $14.9M | $15.8M | -- | -- | -- | -- | -- | -- | ||
Restruct | -- | -- | -- | -- | -- | -- | -- | $1.4M | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | NGNE | $16.91 | -0.4% | 98.28K |
3 | ||||
4 | ||||
5 | ||||
6 |